Related Experiment Video
Updated: May 23, 2026
07:37
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
Glioblastoma--a moving target.
1Uppsala University, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala, Sweden.
Upsala Journal of Medical Sciences
|April 20, 2012
Summary
Glioblastoma research is advancing molecular understanding, focusing on receptor tyrosine kinases and signaling pathways. Targeting glioma stem cells is crucial for future glioblastoma treatment development.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Glioblastoma treatment development lags behind molecular research.
- Key molecular alterations include receptor tyrosine kinase amplification/overexpression (EGFR, PDGFRA) and mutations in PI3K, RB1, and p53 pathways.
Purpose of the Study:
- To highlight the molecular mechanisms driving glioblastoma.
- To emphasize the potential of targeting glioma stem cells for future therapies.
Main Methods:
- Review of current glioblastoma research.
- Analysis of molecular pathways and tumor cell hierarchy.
Main Results:
- Identified critical molecular targets: EGFR, PDGFRA, PI3K, RB1, and p53 pathways.
- Highlighted the role of glioma stem cells in tumor progression and self-renewal.
Conclusions:
- Targeting specific molecular pathways is essential for glioblastoma treatment.
- Reprogramming or blocking self-renewal of glioma stem cells represents a promising future research direction.
